| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_823ea7378559759b8723eb17821050da |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01G31-02 |
| filingDate |
2011-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f380be4c8783d8dd16f66c020835d2f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce121495624f9b9c219ed02ae7ef7fc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77f22adc3eb5c87464101a46d133be5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bfcff2e4189d47d4bb89796890a2306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea9b1ffbe4e6d851bce9522daa78525b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c360386a1f275796f8c20e7e543b47c |
| publicationDate |
2017-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-346646-B |
| titleOfInvention |
PHARMACEUTICAL FORMULATION OF DECAVANADATE OF 4-DIMETHYLAMINOPIRIDINI OR ITS DERIVATIVES, FOR THE PREVENTION AND TREATMENT OF METABOLIC SYNDROME, OBESITY AND DIABETES TYPE 2. |
| abstract |
The present invention provides a pharmaceutical composition comprising 4-dimethylaminopyridinium decavanadate and / or its derivatives. This composition is useful for the prevention and treatment of metabolic syndrome, obesity and type II diabetes. |
| priorityDate |
2011-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |